Covalent modifications (phosphorylation, acetylation, ubiquitination and methylation) of histone N-terminal tails significantly impact chromatin structure and gene transcription. While many of these modifications are regulated dynamically by enzymes of opposing activities, histone methylation has long been considered a """"""""permanent"""""""" modification. We have recently discovered the first histone demethylase LSD1 (Lysine Specific Demethylase 1), which represses transcription by demethylating histone H3 lysine 4 (H3-K4), demonstrating that histone methylation, like other histone modifications, is also regulated dynamically. Our findings raise a number of important and exciting questions. For instance, how is LSD1-mediated demethylation regulated? What are the biological functions of LSD1? Our preliminary findings suggest a potentially very exciting role for BHC80, an LSD1 associated factor, in regulating chromatin events post H3-K4 demethylation mediated by LSD1, and a possible connection to lipid signaling. Investigation of mechanisms by which BHC80 regulates LSD1 is a focus of this application. To understand the biology and in vivo mechanism of action of histone demethylases, we will analyze the roles of S. pombe LSD1 homologs, SPBC146.09C and SPAC23E2.02, in both euchromatin and heterochromatin biology. Pombe heterochromatin is characterized by H3-K9 methylation and H3-K4 hypomethylation, which is consistent with a possible role for LSD1 homologs in heterochromatin. Epigenetic regulation of gene expression via histone modifications has been linked to multiple pathological conditions including cancer. Thus, an understanding of demethylases in heterochromatin as well as euchromatin gene transcription will provide new insights not only into chromatin biology but also cell proliferation control and tumorigenesis in general. Based on our exciting initial results, the proposed studies are likely to result in new paradigms that will significantly impact our views of eukaryotic chromatin and transcriptional regulation. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA118487-02
Application #
7260308
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Okano, Paul
Project Start
2006-07-13
Project End
2011-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
2
Fiscal Year
2007
Total Cost
$292,138
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Sheng, Wanqiang; LaFleur, Martin W; Nguyen, Thao H et al. (2018) LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. Cell 174:549-563.e19
Xiang, Yang; Laurent, Benoit; Hsu, Chih-Hung et al. (2017) RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543:573-576
Jambhekar, Ashwini; Anastas, Jamie N; Shi, Yang (2017) Histone Lysine Demethylase Inhibitors. Cold Spring Harb Perspect Med 7:
Murn, Jernej; Shi, Yang (2017) The winding path of protein methylation research: milestones and new frontiers. Nat Rev Mol Cell Biol 18:517-527
Li, Haojie; Liefke, Robert; Jiang, Junyi et al. (2017) Polycomb-like proteins link the PRC2 complex to CpG islands. Nature 549:287-291
Laurent, B; Shi, Y (2016) Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase. Methods Enzymol 573:241-59
Shen, Hongjie; Xu, Wenqi; Guo, Rui et al. (2016) Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex. Cell 165:331-42
Liefke, Robert; Karwacki-Neisius, Violetta; Shi, Yang (2016) EPOP Interacts with Elongin BC and USP7 to Modulate the Chromatin Landscape. Mol Cell 64:659-672
Ma, Chun; Karwacki-Neisius, Violetta; Tang, Haoran et al. (2016) Nono, a Bivalent Domain Factor, Regulates Erk Signaling and Mouse Embryonic Stem Cell Pluripotency. Cell Rep 17:997-1007
Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei et al. (2015) DNA Methylation on N6-Adenine in C. elegans. Cell 161:868-78

Showing the most recent 10 out of 38 publications